Hostname: page-component-6766d58669-fx4k7 Total loading time: 0 Render date: 2026-05-19T13:11:53.273Z Has data issue: false hasContentIssue false

Serum phosphohexose isomerase levels in patients with head and neck cancer

Published online by Cambridge University Press:  29 June 2007

Harish Goel
Affiliation:
Rohtak, India
G. S. Kohli
Affiliation:
Rohtak, India
Harbans Lal*
Affiliation:
Rohtak, India
*
Dr. Harbans Lal, 12/9J. Medical College, Rohtak-124001 (India).

Abstract

Serum phosphohexose isomerase (PHI) levels were estimated in 28 patients with head and neck cancer. The mean value was significantly higher when compared to the controls. There was no difference in mean PHI value with respect to the character of the lesion or with the histopathological type of growth. The activity was increased with the advancement of the stage of cancer.

With radiotherapy, a gradual and significant decrease in serum PHI activity was observed.

Information

Type
Research Article
Copyright
Copyright © JLO (1984) Limited 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable